Impact of COVID-19 on Sleep Disorder Market: Segmented:By Disorder (Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders), By Device (Sleep Apnea Devices, Sleep Laboratories, Mattresses & Pillows), By Treatment (Psychiatric Treatment, Behavioral Treatment, Cognitive Behavioral Therapy, Medication Therapy) And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
[ 176 + Pages Research Report ]Impact of COVID-19 on Sleep Disorder Market to surpass USD 12.2 billion by 2031 from USD 5.9 billion in 2021 at a CAGR of 7.5% in the coming years, i.e., 2021-2031
Product Overview
Sleep disorder is also known as somnipathy. It is a medical condition where a disorder is generated in the sleep pattern or we can say that it is a group of disorders that impact the sleep pattern on a regular basis. The presence of sleep disorders can be ascribed to different factors including health issues, hectic schedules, and high stress. Lack of quality sleep has a negative impact on the overall health and level of concentration of a person. It leads to tiredness during the day.
Market Highlights
Global Sleep Disorder Market is expected to project a notable CAGR of 7.5% in 2031.
Mental stress is increasing due to hectic life & unhealthy habits are anticipated to propel the growth of the sleep disorder market. Furthermore, the growing usage of social media and increasing addiction to gadgets such as smartphones and laptops augment the market. In addition, the rise in public and private health coverage, covering sleep clinics is boosting the market.
Global Sleep Disorder Market: Segments
Insomnia segment to grow with the highest CAGR during 2021-31
Based on Disorder, the global Sleep Disorder Market is fragmented into Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders. Insomnia is expected to dominate the global sleep disorders market through the forecast period. This can be attributed to the increasing frequency of insomnia, which causes an irresistible sudden loss of muscle tone and daytime sleepiness. The prevalence of sleep disorders has been expressively increasing over the years, which is expected to generate lucrative market growth opportunities.
Sleep apnea devices segment to grow with the highest CAGR during 2021-31
Global Sleep Disorder Market is classified on the basis of devices into sleep apnea devices, sleep laboratories, and mattresses & pillows. Based on the devices, sleep apnea devices are estimated to share the highest market in terms of revenue. Growing demand for early treatment and increasing patient awareness are the major factors estimated to boost the demand for such devices. Furthermore, large number of patient pool seeking for effective diagnosis and treatments are expected to generate lucrative market growth opportunities.
Market Dynamics
Drivers
Increasing awareness regarding the sleep disorders
Increasing awareness about sleep disease among the people and governments of different nations is expected to propel the sleep disorders treatment market. The increasing number of people suffering from various sleep disorders, including hallucinations, sleep paralysis, disrupted nocturnal sleep, insomnia, sleep apnea, narcolepsy, and circadian disorders, caught the attention of governments globally, pushing them to take necessary steps to address this condition.
Product innovation and adoption of different strategies by key market participants
The market is witnessing the development and launch of products that comply with regulatory guidelines Approval and commercialization of new drugs is expected to create lucrative opportunities for the players operating in the global market during the review period.
Restraint
Side-effects associated with a sleep disorder
An increase in patent expirations and related side effects of these drugs would impede the market growth during the forecast period.
Global Sleep Disorder Market: Key Players
Cadwell Laboratories Inc
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
GlaxoSmithKline plc,
Becton Dickson and Company,
Cardinal Health,
Takeda Pharmaceutical Company Limited,
Koninklijke Philips N.V
Teva Pharmaceutical Industries Ltd.
Astellas Pharma Inc,
Cadwell Laboratories Inc.,
Compumedics Limited
Other Prominent Players
Global Sleep Disorder Market: Regions
Global Sleep Disorder Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In North America, the Sleep Disorder market is expected to see remarkable growth during the forecasted period. The increasing number of research studies and growing funding on awareness programs about sleep disorders. Moreover, increasing expenditure on healthcare as well as presence of well-established healthcare sector will augment the industry development.
Impact of Covid-19 on Sleep Disorder Market
Globally, Due to the COVID-19 pandemic has faced unprecedented changes in lives. Such a significant stressful life event is also likely to have raised stress levels and shows an impact on market growth. The concern on health management has risen during COVID-19 which has had a beneficial impact on the market growth.
Global Sleep Disorder Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global Sleep Disorder Market report also contains analysis on:
Sleep Disorder Market Segments:
By Disorder
Insomnia
Hypersomnia
Sleep Apnea
Sleep Breathing Disorders
Circadian Rhythm Disorders
Parasomnia
Sleep Movement Disorders
By Devices
Sleep Apnea Device
Sleep Laboratories
Mattresses & Pillows
By Treatment
Psychiatric Treatment
Behavioral Treatment
Cognitive Behavioral Therapy
Medication Therapy
Sleep Disorder Market Dynamics
Sleep Disorder Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Sleep Disorder Market Report Scope and Segmentation
Report Attribute Details
The market size value in 2021 USD 5.9 billion
The revenue forecast in 2031 USD 12.2 billion
Growth Rate CAGR of 7.5% from 2021 to 2031
The base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Disorder, Device, and Treatment
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA
Key companies profiled GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., and Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc, Cadwell Laboratories Inc.,and Other Prominent Players.
Product Overview
Sleep disorder is also known as somnipathy. It is a medical condition where a disorder is generated in the sleep pattern or we can say that it is a group of disorders that impact the sleep pattern on a regular basis. The presence of sleep disorders can be ascribed to different factors including health issues, hectic schedules, and high stress. Lack of quality sleep has a negative impact on the overall health and level of concentration of a person. It leads to tiredness during the day.
Market Highlights
Global Sleep Disorder Market is expected to project a notable CAGR of 7.5% in 2031.
Mental stress is increasing due to hectic life & unhealthy habits are anticipated to propel the growth of the sleep disorder market. Furthermore, the growing usage of social media and increasing addiction to gadgets such as smartphones and laptops augment the market. In addition, the rise in public and private health coverage, covering sleep clinics is boosting the market.
Global Sleep Disorder Market: Segments
Insomnia segment to grow with the highest CAGR during 2021-31
Based on Disorder, the global Sleep Disorder Market is fragmented into Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders. Insomnia is expected to dominate the global sleep disorders market through the forecast period. This can be attributed to the increasing frequency of insomnia, which causes an irresistible sudden loss of muscle tone and daytime sleepiness. The prevalence of sleep disorders has been expressively increasing over the years, which is expected to generate lucrative market growth opportunities.
Sleep apnea devices segment to grow with the highest CAGR during 2021-31
Global Sleep Disorder Market is classified on the basis of devices into sleep apnea devices, sleep laboratories, and mattresses & pillows. Based on the devices, sleep apnea devices are estimated to share the highest market in terms of revenue. Growing demand for early treatment and increasing patient awareness are the major factors estimated to boost the demand for such devices. Furthermore, large number of patient pool seeking for effective diagnosis and treatments are expected to generate lucrative market growth opportunities.
Market Dynamics
Drivers
Increasing awareness regarding the sleep disorders
Increasing awareness about sleep disease among the people and governments of different nations is expected to propel the sleep disorders treatment market. The increasing number of people suffering from various sleep disorders, including hallucinations, sleep paralysis, disrupted nocturnal sleep, insomnia, sleep apnea, narcolepsy, and circadian disorders, caught the attention of governments globally, pushing them to take necessary steps to address this condition.
Product innovation and adoption of different strategies by key market participants
The market is witnessing the development and launch of products that comply with regulatory guidelines Approval and commercialization of new drugs is expected to create lucrative opportunities for the players operating in the global market during the review period.
Restraint
Side-effects associated with a sleep disorder
An increase in patent expirations and related side effects of these drugs would impede the market growth during the forecast period.
Global Sleep Disorder Market: Key Players
Cadwell Laboratories Inc
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
GlaxoSmithKline plc,
Becton Dickson and Company,
Cardinal Health,
Takeda Pharmaceutical Company Limited,
Koninklijke Philips N.V
Teva Pharmaceutical Industries Ltd.
Astellas Pharma Inc,
Cadwell Laboratories Inc.,
Compumedics Limited
Other Prominent Players
Global Sleep Disorder Market: Regions
Global Sleep Disorder Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In North America, the Sleep Disorder market is expected to see remarkable growth during the forecasted period. The increasing number of research studies and growing funding on awareness programs about sleep disorders. Moreover, increasing expenditure on healthcare as well as presence of well-established healthcare sector will augment the industry development.
Impact of Covid-19 on Sleep Disorder Market
Globally, Due to the COVID-19 pandemic has faced unprecedented changes in lives. Such a significant stressful life event is also likely to have raised stress levels and shows an impact on market growth. The concern on health management has risen during COVID-19 which has had a beneficial impact on the market growth.
Global Sleep Disorder Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global Sleep Disorder Market report also contains analysis on:
Sleep Disorder Market Segments:
By Disorder
Insomnia
Hypersomnia
Sleep Apnea
Sleep Breathing Disorders
Circadian Rhythm Disorders
Parasomnia
Sleep Movement Disorders
By Devices
Sleep Apnea Device
Sleep Laboratories
Mattresses & Pillows
By Treatment
Psychiatric Treatment
Behavioral Treatment
Cognitive Behavioral Therapy
Medication Therapy
Sleep Disorder Market Dynamics
Sleep Disorder Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Sleep Disorder Market Report Scope and Segmentation
Report Attribute Details
The market size value in 2021 USD 5.9 billion
The revenue forecast in 2031 USD 12.2 billion
Growth Rate CAGR of 7.5% from 2021 to 2031
The base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Disorder, Device, and Treatment
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA
Key companies profiled GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., and Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc, Cadwell Laboratories Inc.,and Other Prominent Players.
1. EXECUTIVE SUMMARY
2. GLOBAL SLEEP DISORDER MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL SLEEP DISORDER MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL SLEEP DISORDER MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL SLEEP DISORDER MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Disorder: Market Share (2020-2030F)
12.2.1. Insomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Hypersomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Sleep Apnea, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Sleep Breathing Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Circadian Rhythm Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.6. Parasomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.7. Sleep Movement Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Devices: Market Share (2020-2030F)
12.3.1. Sleep Apnea Devices, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Sleep Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Mattresses & Pillows, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. Treatment: Market Share (2020-2030F)
12.4.1. Psychiatric Treatment, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Cognitive Behavioral Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Behavioral Treatment, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Medication Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Cadwell Laboratories Inc
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. GlaxoSmithKline plc,
13.3. Becton Dickson and Company,
13.4. Cardinal Health,
13.5. Takeda Pharmaceutical Company Limited,
13.6. Koninklijke Philips N.V
13.7. Teva Pharmaceutical Industries Ltd.
13.8. Astellas Pharma Inc,
13.9. Cadwell Laboratories Inc.,
13.10. Compumedics Limited
13.11. Other Prominent Players
14. CONSULTANT RECOMMENDATION
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL SLEEP DISORDER MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL SLEEP DISORDER MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL SLEEP DISORDER MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL SLEEP DISORDER MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Disorder: Market Share (2020-2030F)
12.2.1. Insomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Hypersomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Sleep Apnea, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Sleep Breathing Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Circadian Rhythm Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.6. Parasomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.7. Sleep Movement Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Devices: Market Share (2020-2030F)
12.3.1. Sleep Apnea Devices, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Sleep Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Mattresses & Pillows, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. Treatment: Market Share (2020-2030F)
12.4.1. Psychiatric Treatment, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Cognitive Behavioral Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Behavioral Treatment, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Medication Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Cadwell Laboratories Inc
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. GlaxoSmithKline plc,
13.3. Becton Dickson and Company,
13.4. Cardinal Health,
13.5. Takeda Pharmaceutical Company Limited,
13.6. Koninklijke Philips N.V
13.7. Teva Pharmaceutical Industries Ltd.
13.8. Astellas Pharma Inc,
13.9. Cadwell Laboratories Inc.,
13.10. Compumedics Limited
13.11. Other Prominent Players
14. CONSULTANT RECOMMENDATION
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
